We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.76%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.6B
AUM Growth
+$1.31B
(+11%)
Cap. Flow
+$1.24B
Cap. Flow
% of AUM
9.18%
Top 10 Holdings %
Top 10 Hldgs %
52.17%
Holding
753
New
79
Increased
425
Reduced
211
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$190M |
| 2 |
Enterprise Products Partners
EPD
|
+$96.4M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$94.8M |
| 4 |
Plains All American Pipeline
PAA
|
+$81.9M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$76.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nucor
NUE
|
+$36.6M |
| 2 |
NOV
NOV
|
+$34.2M |
| 3 |
Qualcomm
QCOM
|
+$34.1M |
| 4 |
CenterPoint Energy
CNP
|
+$32.7M |
| 5 |
ConocoPhillips
COP
|
+$31.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 67.49% |
| 2 | Financials | 2.86% |
| 3 | Materials | 2.35% |
| 4 | Healthcare | 2.33% |
| 5 | Industrials | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Paycom
PAYC
$6.78B
| $395K | ﹤0.01% |
8,680
+82
| +1% | +$3.81K |
|
602
Atara Biotherapeutics
ATRA
$71.2M
| $394K | ﹤0.01% |
1,109
-360
| -25% | -$152K |
|
603
Church & Dwight Co
CHD
$23.1B
| $393K | ﹤0.01% |
8,897
+84
| +1% | +$3.83K |
|
604
Minerva Neurosciences
NERV
$188M
| $393K | ﹤0.01% |
+4,181
| New | +$427K |
|
|
EVHC
605
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $393K | ﹤0.01% |
+6,215
| New | +$406K |
|
606
Sturm, Ruger & Co
RGR
$610M
| $392K | ﹤0.01% |
7,439
+70
| +0.9% | +$3.87K |
|
607
American Eagle Outfitters
AEO
$2.85B
| $391K | ﹤0.01% |
25,743
+637
| +3% | +$10.9K |
|
608
Sherwin-Williams
SHW
$78.3B
| $391K | ﹤0.01% |
4,368
-258
| -6% | -$22.8K |
|
609
Euronet Worldwide
EEFT
$3.02B
| $390K | ﹤0.01% |
5,388
+51
| +1% | +$3.94K |
|
|
FOMX
610
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $390K | ﹤0.01% |
+35,173
| New | +$331K |
|
611
Stanley Black & Decker
SWK
$14.2B
| $389K | ﹤0.01% |
3,391
-67
| -2% | -$7.98K |
|
|
AMWD
612
DELISTED
American Woodmark
AMWD
| $388K | ﹤0.01% |
5,153
+49
| +1% | +$3.79K |
|
613
Avery Dennison
AVY
$12.3B
| $388K | ﹤0.01% |
5,525
+52
| +1% | +$3.78K |
|
614
Cato Corp
CATO
$65.9M
| $388K | ﹤0.01% |
12,911
+122
| +1% | +$3.75K |
|
|
BWLD
615
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $388K | ﹤0.01% |
2,513
-75
| -3% | -$11.7K |
|
616
Dolby
DLB
$4.72B
| $385K | ﹤0.01% |
8,513
+81
| +1% | +$3.9K |
|
617
Duluth Holdings
DLTH
$160M
| $385K | ﹤0.01% |
15,143
+143
| +1% | +$4.14K |
|
618
Seres Therapeutics
MCRB
$48M
| $384K | ﹤0.01% |
1,939
-628
| -24% | -$137K |
|
619
Akebia Therapeutics
AKBA
$327M
| $383K | ﹤0.01% |
36,830
-11,630
| -24% | -$100K |
|
620
Manhattan Associates
MANH
$8.97B
| $382K | ﹤0.01% |
7,201
+68
| +1% | +$3.63K |
|
621
Constellation Brands
STZ
$22.2B
| $382K | ﹤0.01% |
+2,491
| New | +$396K |
|
|
TPH
622
DELISTED
Tri Pointe Homes
TPH
| $382K | ﹤0.01% |
33,292
+315
| +1% | +$3.76K |
|
623
Fortune Brands Innovations
FBIN
$6.12B
| $380K | ﹤0.01% |
8,316
-264
| -3% | -$12.5K |
|
624
Ingredion
INGR
$6.38B
| $380K | ﹤0.01% |
3,037
-70
| -2% | -$8.84K |
|
625
MSCI
MSCI
$40B
| $380K | ﹤0.01% |
4,823
-53
| -1% | -$4.27K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, ALPS Advisors held 753 positions worth $13.6B, up 11% from $12.3B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
ALPS Advisors deployed $1.24B of net new capital in Q4 2016, opening 79 new positions and adding to 425 existing holdings. Its largest new stake was Eli Lilly: 558,209 shares worth $41.1M.
By sector, the portfolio is most concentrated in Energy at 67% of assets, up from 66% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Nucor, an estimated $36.6M trimmed.
- ALPS Advisors's largest Q4 2016 buy was Eli Lilly: 558,209 shares worth $41.1M.
- ALPS Advisors added most to Energy Transfer Partners L.p. in Q4 2016, an estimated $190M increase.
- ALPS Advisors's biggest Q4 2016 reduction was Nucor, cutting an estimated $36.6M.
- ALPS Advisors fully exited NOV in Q4 2016, selling an estimated $34.2M.
- ALPS Advisors's ten largest holdings make up 52% of its $13.6B portfolio in Q4 2016.
- ALPS Advisors opened 79 new positions and closed 38 in Q4 2016.
- ALPS Advisors's portfolio value rose 11% quarter-over-quarter to $13.6B.
Based on ALPS Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.